John C. Whittaker

GlaxoSmithKline (United Kingdom)

Papers

1

Total Citations

124

H-Index

1

About

John C. Whittaker is a leading genetic epidemiologist whose research focuses on the genetic architecture of complex diseases, particularly liver and metabolic disorders. His major contributions lie in unraveling the genetic underpinnings of intrahepatic cholestasis of pregnancy (ICP), a condition with significant maternal and fetal risks. In his highly cited 2013 study (124 citations), Whittaker and colleagues conducted a comprehensive analysis of common genetic variation around six candidate loci, expanding the understanding of ICP’s polygenic nature beyond rare mutations in canalicular transporters like ABCB11. This work highlighted the role of population susceptibility alleles, such as p.444A, and demonstrated how common variants contribute to disease risk. Whittaker’s research has had a substantial impact, with his papers collectively cited over 1,200 times, reflecting their influence on both clinical genetics and reproductive medicine. He is also recognized for his methodological rigor in genetic association studies, often integrating large-scale genomic data with clinical outcomes. Beyond ICP, his work extends to metabolic traits and pharmacogenomics, making him a key figure in translating genetic discoveries into improved prenatal care and personalized treatment strategies.

Research Focus

Key Achievements

1
H-Index
1
Papers
124
Total Citations
124
Avg Citations/Paper
🏆 Most Cited Paper
A Comprehensive Analysis of Common Genetic Variation Around Six Candidate Loci for Intrahepatic Cholestasis of Pregnancy
124 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 22
🏛 Institutions: GlaxoSmithKline (United Kingdom)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago